​

MediciNova (MNOV) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

MNOV Stock Rating

MediciNova stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

MNOV Price Target Upside V Benchmarks

TypeNameUpside
StockMediciNova-
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.21$1.21$1.21
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-2---2
Sep, 25-2---2
Aug, 25-2---2
Jul, 25-2---2
Jun, 25-2---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

Dec 21 Dec 23 Dec 24
Dec 21Dec 23Dec 24
Reported$-0.21$-0.17-
Avg Forecast$-0.25$-0.21$-0.22
High Forecast$-0.25$-0.21$-0.22
Low Forecast$-0.25$-0.21$-0.22
Surprise %-16.00%-19.05%-

Revenue Forecast

$500K $1M $2M $3M $4M $5M Dec 21 Dec 23 Dec 24
Dec 21Dec 23Dec 24
Reported$4.04M$1.00M-
Avg Forecast$4.01M$1.00M$750.00K
High Forecast$4.01M$1.00M$750.00K
Low Forecast$4.01M$1.00M$750.00K
Surprise %0.62%--

Net Income Forecast

$-13M $-12M $-11M $-10M $-9M $-9M Dec 21 Dec 23 Dec 24
Dec 21Dec 23Dec 24
Reported$-10.13M$-8.57M-
Avg Forecast$-12.42M$-10.30M$-10.79M
High Forecast$-12.42M$-10.30M$-10.79M
Low Forecast$-12.42M$-10.30M$-10.79M
Surprise %-18.44%-16.78%-

MNOV Forecast FAQ

Is MediciNova stock a buy?

MediciNova stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MediciNova is a favorable investment for most analysts.

What is MediciNova's price target?

MediciNova's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.21.

How does MediciNova stock forecast compare to its benchmarks?

MediciNova's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for MediciNova over the past three months?

  • October 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is MediciNova’s EPS forecast?

MediciNova's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.22, marking a 29.41% increase from the reported $-0.17 in 2023..

What is MediciNova’s revenue forecast?

MediciNova's average annual revenue forecast for its fiscal year ending in December 2024 is $750K, reflecting a -25.00% decrease from the reported $1M in 2023.

What is MediciNova’s net income forecast?

MediciNova's net income forecast for the fiscal year ending in December 2024 stands at $-10.79M, representing an 25.88% increase from the reported $-8.572M in 2023.